S

Author

Sofia Alvarez

FX & Central Banks Editor

Sofia Alvarez has spent 10 years reporting on currency markets and monetary policy, with a focus on Federal Reserve, ECB, and emerging-market central bank decisions. She holds a master's degree in economics from the London School of Economics and previously worked as a macro analyst at a foreign exchange desk. Her coverage explains how policy shifts and rate decisions move currency and bond markets.

Covers:
  • forex
  • central-banks
  • macro
Latest by Sofia Alvarez
Biotechnology Firm Scribe Therapeutics Files for Nasdaq IPO

Biotechnology Firm Scribe Therapeutics Files for Nasdaq IPO

Jul 12, 2026

Scribe Therapeutics has submitted a registration statement for an initial public offering on the Nasdaq Global Market. The biotechnology company plans to trade under the ticker symbol 'SCTX' but has not yet specified the number of shares or price range.